A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Ribociclib (LEE011)|DRUG: Paclitaxel
Sponsor: Abramson Cancer Center at Penn Medicine